Clinical Trial Update: A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression [Phase 2]

View source ↗

Summary

Phase 2 trial of palmitoylethanolamide for bipolar depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Drugs mentioned

• Palmitoylethanolamide (palmitoylethanolamide)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Bipolar Depression | Phase 2 | Status: COMPLETED